Do current therapeutic anti-Aβ antibodies for Alzheimer’s disease engage the target?
Crossref DOI link: https://doi.org/10.1007/s00401-014-1290-2
Published Online: 2014-05-07
Published Print: 2014-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Watt, Andrew D.
Crespi, Gabriela A. N.
Down, Russell A.
Ascher, David B.
Gunn, Adam
Perez, Keyla A.
McLean, Catriona A.
Villemagne, Victor L.
Parker, Michael W.
Barnham, Kevin J.
Miles, Luke A.
Text and Data Mining valid from 2014-05-07